Antonio Gualberto

Years Active: 2021-2021
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

David P Steensma, Martin Wermke, Virginia M Klimek, Peter L Greenberg, Patricia Font, Rami S Komrokji, Jay Yang, Andrew M Brunner, Hetty E Carraway, Lionel Ades, Aref A Al-Kali, Juan M Alonso-Dominguez, Ana Alfonso-Piérola, Catherine C Coombs, H Joachim Deeg, Ian W Flinn, James M Foran, Guillermo Garcia Manero, Michael B Maris, Malgorzata McMasters, Jean-Baptiste Micol, Jaime Perez De Oteyza, Felicitas Thol, Eunice S Wang, Justin M Watts, Justin Taylor, Richard Stone, Vikram Gourineni, Alyssa J Marino, Huilan Yao, Benoit Destenaves, Xiaobin Yuan, Kun Yu, Sara Dar, Lernik Ohanjanian, Keisuke Kuida, Jianjun Xiao, Catherine Scholz, Antonio Gualberto, Uwe Platzbecker
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms. Leukemia 35 (12) (2021)
Alan L Ho, Irene Brana, Robert I Haddad, Jessica Bauman, Keith C Bible, Sjoukje Oosting, Deborah J Wong, Myung-Ju Ahn, Valentina Boni, Caroline Even, Jerome Fayette, Maria José Flor, Kevin J Harrington, Sung-Bae Kim, Lisa F Licitra, Ioanna Nixon, Nabil F Saba, Stephan Hackenberg, Pol Specenier, Francis Worden, Binaifer Balsara, Mollie Leoni, Bridget Martell, Catherine Scholz, Antonio Gualberto
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (17) (2021)

Antonio Gualberto.css-eqlu8i{font-size:small;padding-left:4px;}